Enhancing Health Literacy Through AI-Powered Chatbot: a Randomized Controlled Trial

Launched by THE UNIVERSITY OF HONG KONG · Nov 20, 2024

Keywords

ClinConnect Summary

This clinical trial is exploring whether an AI-powered chatbot can help improve health literacy about the Human Papillomavirus (HPV) vaccine among female caregivers in Japan. The aim is to see if using this digital tool makes it easier for caregivers to understand the importance of HPV vaccination for their daughters, who are aged 12 to 18 and have not yet received the vaccine.

To participate, caregivers need to have access to a smartphone or computer and be able to read and understand the materials provided. They will start by completing a survey before using the chatbot or reading an online leaflet about HPV vaccination. After interacting with the chatbot or leaflet for two weeks, they will answer another survey to share what they learned. This trial is not currently recruiting participants, so if you meet the criteria, keep an eye out for when it starts!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • A nationally representative sample of female caregivers with daughters aged 12-18 who have not received any HPV vaccine.
• • Those who have access to a smartphone or computer with internet connectivity to interact with experiment materials (chatbot or online leaflet).
• • Those who provide informed consent and agree to participate in the study.
• Exclusion Criteria:
• • Those who need help reading through the participant information sheet, providing consent online, accessing experiment materials (chatbot or online leaflet), or answering surveys will be excluded. This may include people who do not have access to an online environment or people with severe cognitive impairments who cannot interact with the experiment materials. Also, those who have participated or are participating in similar studies regarding vaccination or experiments that utilize chatbots will be excluded.